These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23964462)

  • 1. Chronological production of thioacetamide-induced cirrhosis in the rat with no mortality.
    Norasingha A; Pradidarcheep W; Chayaburakul K
    J Med Assoc Thai; 2012 Jan; 95 Suppl 1():S173-7. PubMed ID: 23964462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited.
    Laleman W; Vander Elst I; Zeegers M; Servaes R; Libbrecht L; Roskams T; Fevery J; Nevens F
    Eur J Clin Invest; 2006 Apr; 36(4):242-9. PubMed ID: 16620286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is anorexia in thioacetamide-induced cirrhosis related to an altered brain serotonin concentration?
    Haider S; Saleem S; Shameem S; Ahmed SP; Parveen T; Haleem DJ
    Pol J Pharmacol; 2004; 56(1):73-8. PubMed ID: 15047980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of zedoary turmeric oil on P450 activities in rats with liver cirrhosis induced by thioacetamide.
    Cheng JJ; Yang NB; Wu L; Lin JL; Dai GX; Zhu JY
    Int J Clin Exp Pathol; 2014; 7(11):7854-62. PubMed ID: 25550825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of alpha-mangostin against type-I collagen formation in thioacetamide-induced cirrhotic rat.
    Poonkhum R; Watanapokasin R; Pradidarcheep W
    J Med Assoc Thai; 2012 Dec; 95 Suppl 12():S93-8. PubMed ID: 23513472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid.
    Reif S; Aeed H; Shilo Y; Reich R; Kloog Y; Kweon YO; Bruck R
    J Hepatol; 2004 Aug; 41(2):235-41. PubMed ID: 15288472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protein expression profiles in a rat cirrhotic model induced by thioacetamide].
    An JH; Seong J; Oh H; Kim W; Han KH; Paik YH
    Korean J Hepatol; 2006 Mar; 12(1):93-102. PubMed ID: 16565610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme (ACE) gene expression in experimentally induced liver cirrhosis in rats.
    Shahid SM; Fatima SN; Mahboob T
    Pak J Pharm Sci; 2013 Sep; 26(5):853-7. PubMed ID: 24035938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pravastatin for thioacetamide-induced hepatic failure and encephalopathy.
    Huang HC; Chang CC; Wang SS; Chan CY; Lee FY; Chuang CL; Hsin IF; Teng TH; Lin HC; Lee SD
    Eur J Clin Invest; 2012 Feb; 42(2):139-45. PubMed ID: 21749370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of melatonin against thioacetamide-induced liver fibrosis in rats.
    Czechowska G; Celinski K; Korolczuk A; Wojcicka G; Dudka J; Bojarska A; Reiter RJ
    J Physiol Pharmacol; 2015 Aug; 66(4):567-79. PubMed ID: 26348081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of portocaval shunt on bile flow and maximal biliary excretion of bromsulfophthalein sodium (BSP) in rats with thioacetamide induced liver cirrhosis.
    Bodnár A; Karácsonyi S; Zsigmond G
    Z Exp Chir; 1981 Feb; 14(1):35-9. PubMed ID: 7234017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-carotene attenuates experimentally induced liver cirrhosis in rats.
    Wardi J; Reifen R; Aeed H; Zadel L; Avni Y; Bruck R
    Isr Med Assoc J; 2001 Feb; 3(2):151-4. PubMed ID: 11344828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of selenium in protection of liver cirrhosis.
    Fatima SN; Mahboob T
    Pak J Pharm Sci; 2013 Nov; 26(6):1097-102. PubMed ID: 24191312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of erythrocytes to lipid peroxidation in cirrhotic rats.
    Oztezcan S; Balkan J; Dogru-Abbasoglu S; Cevikbas U; Aykaç-Toker G; Uysal M
    Arch Med Res; 2005; 36(5):459-63. PubMed ID: 16099321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis.
    Bruck R; Schey R; Aeed H; Hochman A; Genina O; Pines M
    Liver Int; 2004 Apr; 24(2):169-76. PubMed ID: 15078482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expressional changes of carbamoyl phosphate synthetase and glutamine synthetase in the liver of rat with thioacetamide-induced cirrhosis.
    Khunvirojpanich M; Wattanasirichaigoon S; Pradidarcheep W
    J Med Assoc Thai; 2013 Jan; 96 Suppl 1():S71-7. PubMed ID: 23724459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoprotective activity of a phytotherapeutic formula on thioacetamide--induced liver fibrosis model.
    Kantah MK; Kobayashi R; Sollano J; Naito Y; Solimene U; Jains S; Catanzaro R; Minelli E; Polimeni A; Marotta F
    Acta Biomed; 2011 Apr; 82(1):82-9. PubMed ID: 22069962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats.
    Constantinou MA; Theocharis SE; Mikros E
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):11-9. PubMed ID: 17113614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamics in the microvasculature of thioacetamide-induced cirrhotic rat livers.
    Nakata M; Nakamura K; Koda Y; Kaminou T; Ugami M; Kaneda K; Yamada R
    Hepatogastroenterology; 2002; 49(45):652-6. PubMed ID: 12063962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.